Is Patient Safety The Low-Hanging Fruit of Personalized Medicine?">
Is Patient Safety The Low-Hanging Fruit of Personalized Medicine?">
Clinician Adoption of Genetic Testing for Drug Metabolizing Enzymes: Is Patient Safety The Low-Hanging Fruit of Personalized Medicine? | AMIA Knowledge Center
You must log in to view this content. All contents are accessible to AMIA members and meeting attendees. If you are interested in purchasing proceedings, please contact us at mail@amia.org